SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 9 of 37
Health
Pfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show
By
Antony Sguazzin
,
Jason Gale
and
Bloomberg
December 8, 2021
Health
GSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments
By
Sophie Mellor
December 7, 2021
Health
Omicron vaccine to begin clinical trial in South Africa
By
Jeremy Kahn
December 6, 2021
Newsletters
Global stocks rebound as investors shrug off the Omicron risk. Crypto pain continues
By
Bernhard Warner
December 6, 2021
Health
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
By
Suzi Ring
,
Irina Anghel
and
Bloomberg
December 3, 2021
Health
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
By
Christiaan Hetzner
December 2, 2021
Health
Why COVID pills are likely to maintain efficacy against the Omicron COVID variant—even if vaccines don’t
By
Grady McGregor
December 1, 2021
Health
COVID infections are rising again as the Omicron variant emerges in nearly 20 countries
By
Erika Fry
and
Nicolas Rapp
November 30, 2021
Health
Biden says he’s not considering lockdowns in fight against Omicron COVID variant
By
Marco Quiroz-Gutierrez
November 29, 2021
Health
Global drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
By
Yvonne Lau
November 29, 2021
Newsletters
The Omicron bounce: crypto, crude and stocks rebound as virus jitters ease
By
Bernhard Warner
November 29, 2021
Health
Pfizer COVID shots are 100% effective for 12 to 15 year olds, study says
By
Felicia Hou
November 24, 2021
Newsletters
The world has changed but many boards ‘have not moved on’
By
David Meyer
and
Alan Murray
November 19, 2021
Newsletters
What the CEOs of Walgreens, Hilton and Progressive think about the Great Resignation
By
David Meyer
and
Alan Murray
November 18, 2021
Newsletters
Resiliency, climate and China: Lessons from Day 2 of the Fortune CEO Initiative
By
David Meyer
and
Alan Murray
November 17, 2021
Most Popular
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
Success
Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
By
Emma Burleigh
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith